Novo Nordisk vows legal action to protect Wegovy pill / Medical Express

medicalxpress - Novo Nordisk said Thursday it would take legal action against a US chain offering a copycat of the new pill version of its Wegovy weight-loss drug.

#obesity #healthcare #pharmaceuticals #drugpricing #novonordisk #weightloss #drugdevelopment #digitalhealth

Novo Nordisk to expand Irish factory for Wegovy pill

26 days / endpoints / Anna Brown

Blockbuster weight loss drugs like Ozempic deliver big results but face big questions

28 days / sciencedaily

Why people won't quit a weight loss drug, even when it makes them feel sick

28 days / medicalxpress

FDA to Novo Nordisk: Correct ‘misleading’ GLP-1 pill TV ad

28 days / beckershospitalreview / Erica Cerutti

The fallout from Novo vs. Hims

29 days / endpoints / Lydia Ramsey Pflanzer

Hims pulls cheaper Wegovy pill after federal scrutiny

29 days / medicalxpress

Hims retreats from weight loss pill launch as Novo, FDA pressure mounts

4 wks / fiercehealthcare

After industry pressure, Hims & Hers stops selling Wegovy pill

4 wks / beckershospitalreview / Paige Twenter

Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking 'hundreds of millions' in damages

4 wks / endpoints / Elizabeth Cairns

'Weight-loss jab helped me find my cancer'

4 wks / bbc

Hims & Hers Withdraws Knockoff Weight-Loss Pill After Regulatory Scrutiny

4 wks / nytimes / Rebecca Robbins

Hims says it will stop selling GLP-1 pill, after legal pressure from US

4 wks / endpoints / Drew Armstrong

The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more

4 wks / endpoints / Max Gelman

US calls for DOJ investigation of Hims over GLP-1 drugs

4 wks / endpoints / Shelby Livingston

Synergizing global clinical trials data: GLP-1 receptor agonist safety and novel clinical applications

4 wks / medicalxpress

FDA's Makary pledges crackdown on mass marketing of 'illegal copycat drugs' in wake of Hims' Wegovy pill push

4 wks / fiercehealthcare

FDA chief Makary takes aim at Hims' compounded Wegovy pill plans

4 wks / endpoints / Max Bayer

Novo's threat to sue Hims over Wegovy pill faces legal hurdle

4 wks / endpoints / Shelby Livingston

War breaks out over GLP-1 pills

4 wks / beckershospitalreview / Paige Twenter

Novo Nordisk vows legal action to protect Wegovy pill

4 wks / medicalxpress

Him & Hers plans to offer cheaper version of Wegovy pill, prompting Novo Nordisk to threaten legal action

4 wks / fiercehealthcare

Telehealth provider Hims goes after Novo's weight-loss pill with compounded version

4 wks / endpoints / Zachary Brennan

Thursday, February 5, 2026, 3:23 pm / permalink 18807 / 22 stories in 4 wks



Related Stories



Related Tags


Obesity

Eli Lilly launches Employer Connect to broaden GLP‑1 coverage (3 days)

GLP‑1 drugs associated with lower addiction risk in large study (4 days)

Novo Nordisk commits $2.1B to Vivtex to pursue oral obesity medicines (8 days)

more #obesity


Healthcare

Judge orders Leapfrog to remove safety grades for five Florida hospitals (21 hrs)

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis (40 hrs)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

more #healthcare


Pharmaceuticals

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity (2 days)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

Eli Lilly launches Employer Connect to broaden GLP‑1 coverage (3 days)

more #pharmaceuticals


StackHealth Time Machine



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.